Acral Melanoma

• CLINICAL_TRIALS research · 2026-03-30
  Clinical Trial Update: Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma [Phase 2]

  A Phase 2 neoadjuvant trial is evaluating pucotenlimab with lenvatinib and temozolomide for resectable acral melanoma (Stage IIB/III); the s…

• CLINICAL_TRIALS research · 2026-01-16
  Clinical Trial Update: Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma [Phase 2]

  Phase 2 clinical trial evaluating a combination including iparomlimab and tuvoraleimab with bevacizumab, nab-paclitaxel, and carboplatin as …

• CLINICAL_TRIALS research · 2025-11-12
  Clinical Trial Update: Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial [Phase 2]

  Phase 2 trial evaluating time-of-day specified immunotherapy for advanced melanoma; currently recruiting.

• CLINICAL_TRIALS research · 2025-05-11
  Clinical Trial Update: Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial [Phase 2]

  A Phase II trial evaluating perioperative toripalimab and endostatin for stage II melanoma is currently recruiting, sponsored by Fudan Unive…

• CLINICAL_TRIALS research · 2025-04-04
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy [Phase 2]

  Phase 2 study evaluating IBI363 monotherapy versus pembrolizumab for unresectable locally advanced or metastatic mucosal or acral melanoma i…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma [Phase 2]

  This clinical trial update describes a Phase 2 neoadjuvant study of camrelizumab plus apatinib and temozolomide in high-risk acral melanoma …

• CLINICAL_TRIALS research · 2024-10-28
  Clinical Trial Update: An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

  This observational study evaluates the LumAssure device in participants undergoing assessment of various skin conditions (including basal ce…